MD+DI, December, Volume 33, No. 12

December 2011


This Issue's Articles
State of Medtech 2011 and Beyond: A SWOT Analysis
by: Heather Thompson

Inside Look: AdvaMed Pursuing a Six-Point Plan for Success
The advocacy group hopes its competitiveness agenda will help industry in 2012.

The 510(k) Program Should Be Saved, Not Scorned
FDA is mismanaging what would otherwise be a good regulatory framework.
by: Jim Dickinson

CDRH Director Shuren to Speak at LifeScience Alley

Democrats Want Hearings to Examine Device Safety

Taking a Firmer Hand, Shuren Works to Make CDRH More Consistent, Predictable

Industry Rejects Funding FDA Bonuses with User Fees

Approval Granted to Mela Sciences

MDDI 2011 Salary Survey: Research and Development

MDDI 2011 Salary Survey: Regulatory and Legal Affairs

MDDI 2011 Salary Survey: Quality Assurance and Quality Control

MDDI 2011 Salary Survey: Production and Manufacturing

MDDI 2011 Salary Survey: Product Design Engineering

MDDI 2011 Salary Survey: General and Corporate Management

A Tough Year for U.S. Medical Device Manufacturing
OEMs had a hard 2011. Will 2012 be better?
by: Jamie Hartford

Many Medtech Companies Struggled to Find Funding in 2011
by: Brian Buntz

Though 510(k) Program Faced Heavy Criticism, Numbers Showed It to Fared Better than PMAs
by: Thomas Blair

MedTech Snapshot International: Are the Next Eleven the Next Frontier?
by: Maria Fontanazza

Mergers and Acquisitions: Medtech Buyers and Sellers Win
In 2011, the medtech market saw a major uptick in mergers and acquisitions.
by: Clyde A. Burkhardt

The Best (and Worst) Thing About Medtech Jobs—An MD+DI Salary Survey Guide

A Look at Medical Device Numbers in 2011
The medical device market is facing a number of hurdles, which are having a negative influence on job growth, the funding climate, and the industry’s overall prognosis.

AdvaMed Ramps Up Political Spending in Third Quarter

Inside Look: MDMA to Target Regulatory Process
 Next year, the association will also continue to fight the device tax.